Delivery Order SPE2DB20D3505-SPE2DB25FYCHV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets in quantities of 100 on August 5, 2025, with completion targeted for August 6, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $1,573.16 and operates under firm fixed price terms. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the awardee location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,079.18 to supply Nateglinide 120 mg tablets (100-count units) under a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside award was competitively procured and represents a child contract action originating from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the company's...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,188,368 units of Nateglinide 60 mg tablets. The contract has a ceiling value of $3,385.38 and an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nateglinide 60 mg tablets. The contract has a ceiling value of $4,166.99 and runs through April 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,842.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,875,756 units of the medication Nateglinide 60 mg Tablet in 100-count packages. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 11, 2025. It is not designated as a set-aside contract,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $837 to Amerisourcebergen Drug Corporation for the supply of 30 boxes of 60mg Nateglinide tablets. Performance will take place in Conshohocken, Pennsylvania over a two day period in early August 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its Corporate Office Division location. No major subcontractors or set aside designations were indicated. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,675.22 firm-fixed-price delivery order is for the supply of 4,566,177,969 units of the medication Nateglinide 120 mg Tablet UD 30s. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of nateglinide 120 mg tablets. The contract has a ceiling value of $2,183.16 and was awarded on August 12, 2021, with an ultimate completion date of August 13, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency Troop Support Medical awarded a $427,640 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561322346 Nateglinide 120 mg tablets packaged in quantities of 100 tablets. The place of performance for the contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from June 23, 2023 through June 26, 2023. No subcontractors or set aside designations were identified. The Defense...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,711,486 units of Nateglinide 60 mg Tablets in 100-count packages, with a ceiling value of $4,803.26. The contract is a firm fixed-price delivery order, with a period of performance ending on July 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCHVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nateglinide 60 mg tablets (100-count units) with a ceiling value of $1,554.62. This firm fixed-price delivery order, which has a completion date of September 10, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading pharmaceutical distributors and serves as a critical supplier to federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order represents a continuation of AmerisourceBergen Drug Corp's extensive work under its larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent contract functions as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Nateglinide, a diabetes medication, aligns with AmerisourceBergen's established portfolio of therapeutic products and demonstrates the company's role as a strategic vendor for federal medical supply chains supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/9/25 |